MURATORI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 8.344
AS - Asia 6.880
EU - Europa 5.176
AF - Africa 411
SA - Sud America 338
OC - Oceania 21
Totale 21.170
Nazione #
US - Stati Uniti d'America 8.240
VN - Vietnam 2.147
CN - Cina 1.725
SG - Singapore 1.690
GB - Regno Unito 1.312
IT - Italia 860
DE - Germania 719
SE - Svezia 629
HK - Hong Kong 379
FR - Francia 324
IN - India 319
UA - Ucraina 304
RU - Federazione Russa 263
BR - Brasile 210
IE - Irlanda 169
JP - Giappone 125
NL - Olanda 112
FI - Finlandia 103
ZA - Sudafrica 102
KR - Corea 95
BD - Bangladesh 93
EE - Estonia 86
CI - Costa d'Avorio 83
SC - Seychelles 74
TG - Togo 70
CH - Svizzera 66
AR - Argentina 61
CA - Canada 60
PH - Filippine 52
BG - Bulgaria 34
TR - Turchia 34
AT - Austria 32
TH - Thailandia 31
BE - Belgio 30
JO - Giordania 30
PL - Polonia 28
ID - Indonesia 27
MX - Messico 26
IQ - Iraq 25
EC - Ecuador 22
GR - Grecia 21
NG - Nigeria 21
PK - Pakistan 19
TW - Taiwan 17
HR - Croazia 16
AU - Australia 14
RO - Romania 13
EG - Egitto 12
ES - Italia 12
MA - Marocco 12
IR - Iran 11
SA - Arabia Saudita 11
TN - Tunisia 11
MY - Malesia 9
KE - Kenya 8
LT - Lituania 8
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
PE - Perù 7
PT - Portogallo 7
PY - Paraguay 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
NZ - Nuova Zelanda 6
DZ - Algeria 5
OM - Oman 5
AO - Angola 4
BO - Bolivia 4
CR - Costa Rica 4
LB - Libano 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
AL - Albania 3
JM - Giamaica 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
Totale 21.155
Città #
Singapore 1.158
Southend 1.129
Fairfield 828
Ashburn 827
Chandler 595
Dong Ket 585
San Jose 442
Woodbridge 402
Houston 391
Seattle 388
Santa Clara 379
Ho Chi Minh City 373
Hong Kong 353
Wilmington 352
Hanoi 329
Cambridge 294
Princeton 253
Ann Arbor 247
Hefei 212
Beijing 201
Jacksonville 194
Boardman 171
Dublin 168
Bologna 146
Lauterbourg 117
Nanjing 116
Tokyo 107
Council Bluffs 106
Padova 103
Los Angeles 101
Westminster 101
Frankfurt am Main 95
Berlin 91
Helsinki 86
Jinan 85
Abidjan 83
Buffalo 71
Lomé 70
Seoul 69
Milan 67
Da Nang 65
New York 65
Shenyang 60
Dallas 59
Haiphong 58
Saint Petersburg 53
Bern 52
San Diego 51
Changsha 44
Des Moines 42
Hebei 40
Bremen 39
Mülheim 39
Guangzhou 37
Phoenix 36
Rome 36
Shanghai 36
Nanchang 35
Tianjin 34
Sofia 32
Turin 32
Amman 30
Redondo Beach 30
Brussels 28
Zhengzhou 28
Munich 27
São Paulo 27
London 26
Hangzhou 25
Bengaluru 24
Medford 24
Haikou 21
Abeokuta 20
Chengdu 20
Mahé 20
Can Tho 19
Falls Church 19
Hải Dương 19
Jiaxing 19
Orem 19
Taiyuan 19
Vienna 19
Washington 19
Chicago 18
Dearborn 18
Nuremberg 18
San Francisco 18
Bühl 17
Toronto 17
Amsterdam 16
Biên Hòa 16
Montreal 16
Taizhou 16
Fremont 15
Fuzhou 15
Modena 15
Moscow 15
Ningbo 15
Ninh Bình 15
Verona 15
Totale 13.607
Nome #
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 299
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 279
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 277
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 264
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 258
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 257
Clinical and serological profile of primary biliary cirrhosis in men. 246
Antinuclear antibodies in COVID 19 244
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 238
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 238
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 238
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 236
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 232
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 230
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 226
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 226
Autoimmune enteropathy and rheumatoid arthritis: A new association in the field of autoimmunity. 220
Anti-actin IgA antibodies in severe coeliac disease 216
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 213
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 210
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. 206
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 206
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 205
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 205
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 204
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 202
A case of leptospirosis simulating colon cancer with liver metastases 200
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 200
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 199
Autoantibodies in Autoimmune Hepatitis 199
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 199
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 197
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 196
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 194
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry 191
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 191
Diagnosis and therapy of autoimmune hepatitis. 190
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 187
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 187
Autoimmune liver disease 2007. 186
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 185
Blood-Based Non-Invasive Tests of Hepatic Fibrosis in Autoimmune Hepatitis: Application among Selected Patients Leads to Higher Accuracy 183
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 183
Autoimmune hepatitis in Italy: the Bologna experience. 180
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 180
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 179
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 177
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 177
Antitransglutaminase antibodies and giardiasis 176
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 175
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 175
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 172
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 172
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 172
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 171
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 170
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 169
Specific antinuclear reactivities in primary biliary cirrhosis 168
Deamidated gliadin Peptide antibodies as a routine test for celiac disease: a prospective analysis. 168
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 168
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. 165
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 165
Standardization of Autoantibody Testing in Autoimmune Hepatitis 164
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 163
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 162
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 160
Diagnostic approach to autoimmune hepatitis 160
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 159
Celiac disease in autoimmune cholestatic liver disorders 159
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 157
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 153
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 152
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 149
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 147
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 147
Diagnosis of primary biliary cholangitis in a "teen" male patient 146
Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis 144
Le fonti energetiche rinnovabili nel contesto internazionale: il solare fotovoltaico ed i suoi sviluppi tecnologici 143
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 143
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 142
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 142
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 142
Development of autoimmune hepatitis after influenza vaccination; trigger or killer? 142
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 141
Response to Efe et al. 139
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 139
Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing 139
Coronavirus disease associated immune thrombocytopenia: Causation or correlation? 137
Numerical investigation of blood flow in a stenotic artery. Target 1: geometry and rheology 136
Serum Smooth Muscle Antibodies (SMA). 135
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting 135
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C 134
Acute-on-chronic liver failure: A complex clinical entity in patients with autoimmune hepatitis 134
Genetic distinction between autoimmune hepatitis in Italy and North America 133
Usefulness of Antibodies to Deamidated Gliadin Peptides in Celiac Disease Diagnosis and Follow-up. 133
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 132
Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis 132
Autoantibodies to speckled protein family in primary biliary cholangitis 128
A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center 124
Hepatitis C and autoreactivity. 123
Totale 18.071
Categoria #
all - tutte 63.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 0 0 0 0 0 0 0 0 0 0 0 827
2021/20222.455 211 49 169 220 201 124 50 168 100 177 567 419
2022/20232.442 326 342 128 314 139 186 87 135 388 95 189 113
2023/2024667 48 112 44 67 61 98 32 55 22 33 49 46
2024/20252.710 156 422 292 211 485 130 135 57 42 153 92 535
2025/20266.732 479 552 502 467 717 393 640 177 1.637 551 341 276
Totale 21.514